Oxidized low-density lipoproteins and atherosclerosis

Journal of Clinical and Basic Cardiology

Volumn 3, Issue 2, 2000, Pages 87-88

  Yla Herttuala S ^a   Pakkanen, T ^a   Leppanen P ^a   Hakkinen T ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Antioxidative mechanisms; Atherogenesis; Free radicals; Oxidative mechanisms

Indexed keywords

FREE RADICAL; LOW DENSITY LIPOPROTEIN;

ARTERY WALL; ATHEROGENESIS; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; HUMAN; IN VIVO STUDY; LIPID COMPOSITION; LIPID PEROXIDATION; MACROPHAGE ACTIVATION; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; VASCULAR DISEASE;

EID: 0033806270     PISSN: 15612775     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. WHO MONICA Project: Assessing CHD mortality and morbidity
2. Role of oxidized low density lipoprotein in atherogenesis
3. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man
4. Role of lipid and lipoprotein oxidation in the pathogenesis of atherosclerosis
5. Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide
6. Type I macrophage scavenger receptor contains a-helical and collagen-like coiled coilds
7. Expression of lipoprotein receptors and related molecules in atherosclerotic lesions
8. Oxidative modification of low density lipoprotein and its relation to atherosclerosis
9. The role of lipid peroxidation and antioxidants in oxidative modification of LDL
10. The role of oxidized low-density lipoprotein in atherogenesis
11. Low density lipoprotein undergoes oxidative modification in vivo
12. Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized LDL
13. Is oxidized LDL present in vivo?
14. Cigarette smoking potentiates endothelial dysfunction of forearm resistance vessels in patients with hypercholesterolemia: Role of oxidized LDL
15. Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: Evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks slowing the progression of atherosclerosis in the WHHL rabbit
16. Effects of d-a-tocopherol supplementation on experimentally induced primate atherosclerosis
17. The antioxidant butylated hydroxytoluene protects against atherosclerosis
18. Low density lipoprotein is protected from oxidation and the progression of atherosclerosis is slowed in cholesterol-fed rabbits by the antioxidant N,N'-diphenylphenylenediamine
19. Biochemical and cytotoxic characteristics of an in vivo circulating oxidized low density lipoprotein (LDL-)
20. Vitamin E consumption and the risk of coronary disease in women
21. Vitamin E consumption and the risk of coronary heart disease in men
22. Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women
23. Antioxidant vitamin intake and coronary mortality in a longitudinal population study
24. Nutrition intervention trials in Linxian, China: Supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population
25. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers
26. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease
27. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease
28. The effect of probucol on femoral atherosclerosis: The probucol quantitative regression Swedish trial (PQRST)
29. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS)
30. Dietary antioxidant flavonoids and risk of coronary heart disease: The Zutphen elderly study